Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

emcure pharmaceuticals ltd. - amlodipine (amlodipine besilate), hydrochlorothiazide - tablets - 2,5mg+12,5mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

emcure pharmaceuticals ltd. - tenofovir disoproxil fumarate - tablets film-coated - 300mg

United States - English - NLM (National Library of Medicine)

sandoz inc - lorazepam (unii: o26fzp769l) (lorazepam - unii:o26fzp769l) - lorazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety associated with depressive symptoms. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the effectiveness of lorazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug for the individual patient. lorazepam is contraindicated in patients with – hypersensitivity to benzodiazepines or to any components of the formulation. – acute narrow-angle glaucoma.

United States - English - NLM (National Library of Medicine)

dispensing solutions, inc. - lorazepam (unii: o26fzp769l) (lorazepam - unii:o26fzp769l) - lorazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety associated with depressive symptoms. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the effectiveness of lorazepam in long-term use, that is more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug for the individual patient. lorazepam is contraindicated in patients with - hypersensitivity to benzodiazepines or to any components of the formulation. - acute narrow-angle glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

multigate medical devices pty ltd - 35211 - needle, scalp vein - a very slender, sharply pointed instrument designed for use on the veins of the scalp or other small veins, especially in paediatric patients. this needle comes with an extension line.

Australia - English - Department of Health (Therapeutic Goods Administration)

multigate medical devices pty ltd - 12159 - intravenous administration set, buret - an administration set, containing a calibrated burette for fluid volume measurement, used to deliver accurately measured volumes of intravenous solutions to the infusion site. it may have a variety of connections, clamps, lengths, and injection ports. it is typically used for gravitational intravenous administration or with an infusion pump. this is a sterile, single-use device.

Australia - English - Department of Health (Therapeutic Goods Administration)

multigate medical devices pty ltd - 46102 - irrigation tubing set, general purpose - a device intended to deliver irrigation solutions used in surgical procedure (eg. arthroscopy, cystoscopy).

Australia - English - Department of Health (Therapeutic Goods Administration)

multigate medical devices pty ltd - 32172 - infusion stopcock - a component of an intravenous administration kit that regulates fluid delivery to a patient's vascular system. it is a single use device.

United States - English - NLM (National Library of Medicine)

vivimed labs limited - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine tablets, usp is indicated in: 1. short – term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. 2. maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. no placebo–controlled comparative studies have been carried out for periods of longer than 1 year. 3. the treatment of pathological hypersecretory conditions (e.g., zollinger–ellision syndrome and systemic mastocytosis). 4. short–term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. 5. maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. placebo–controlled studies have been

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - carefully consider the potential benefits and risks of ibuprofen tablets and other treatment options before deciding to use ibuprofen. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ibuprofen tablets are indicated for relief of mild to moderate pain. ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea. controlled clinical trials to establish the safety and effectiveness of ibuprofen tablets in children have not been conducted. ibuprofen tablets are contraindicated in patients with known hypersensitivity to ibuprofen. ibuprofen tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reac